Benitec Biopharma Financial Overview
Benitec Biopharma's market cap is currently $443.60M. The company's EPS TTM is $-0.22; its P/E ratio is -13.03; Benitec Biopharma is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-0.22. See an overview of income statement, balance sheet, and cash flow financials.
